Michael A. RobinsonToday I want to reintroduce you to a biotech stock that Wall Street has been pricing as though it were dead money.This biotech company recently filed a stellar earnings report. But those earnings were slightly off analyst expectations, and the share price dipped – making this is yet another stock that sells off after a slight miss, a […]
SummaryDoing due diligence on a small portion of the mosaic theory related to Inovio and other biotechs led me to doing a small initial study on RedChip.
While RedChip has Inovio listed prominently in multiple areas on its website and has recently Tweeted about it, Inovio is not a client and has never paid RedChip.
Biotech and healthcare stocks listed as RedChip […]
Once again, deals and collaborations made news in the biotech sector with BioMarin (BMRN – Analyst Report) announcing its intention to acquire Prosensa (RNA – Snapshot Report) and Five Prime Therapeutics (FPRX – Snapshot Report) signing a second immuno-oncology focused deal with Bristol-Myers Squibb.Meanwhile, AbbVie (ABBV – Analyst Report) continues to progress with its hepatitis C virus (HCV) treatment with […]
William Patalon III: When I earned my MBA from the Rochester Institute of Technology (RIT) back in the mid-1990s, my focus was finance and investing.But it was a management professor who clued me in to some of the best ways to “look past the numbers” and understand what really makes a big company tick.The professor, Janet C. Barnard, retired a few […]
Two Biotech Stocks Set to Double on One Powerful CatalystCompanies / BioTechNov 21, 2014 – 02:46 PM GMTBy: Money_MorningWilliam Patalon writes: When I earned my MBA from the Rochester Institute of Technology (RIT) back in the mid-1990s, my focus was finance and investing.But it was a management professor who clued me in to some of the best ways to “look […]
William Patalon IIIWhen I earned my MBA from the Rochester Institute of Technology (RIT) back in the mid-1990s, my focus was finance and investing.But it was a management professor who clued me in to some of the best ways to “look past the numbers” and understand what really makes a big company tick.The professor, Janet C. Barnard, retired a few […]
Biotech stocks surged nicely Tuesday with the iShares Biotechnology ETF rallying more than 2 percent.For the most part, biotech stocks have performed very well over the last month and even the last year.That performance can be seen quite well with names such as Gilead Sciences, Illumina and Vertex Pharmaceuticals all having hit new highs within the last 30 days.However, not […]
Geron Corporation (GERN – Analyst Report) was in the spotlight last week with the company striking a collaboration deal with Johnson & Johnson for its sole pipeline candidate, imetelstat. Meanwhile, companies like Gilead (GILD – Analyst Report) and Regeneron (REGN – Analyst Report) remained in the news thanks to regulatory updates.Recap of the Week’s Most Important Stories1. Geron, which had […]
Last week’s market price action was somewhat like watching paint peel. In other words, there just wasn’t much going on.Even though the market edged higher for the fourth straight week and the S&P 500 hit new record highs, the gains came during the smallest market moves since 1979.After Monday, the benchmark S&P rose or fell less than 0.1 percent on […]
The number of patients with this chronic liver disease, which can lead to permanent liver scarring, eclipses that of hepatitis C in the U.S., RBC’s Yee said. While a significant number aren’t diagnosed, “we believe, based on survey work, that there are hundreds of thousands of patients with diagnosed NASH,” and that the global market for NASH drugs may reach […]
